Pancrelipase + Pancrelipase
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Cystic Fibrosis
Conditions
Cystic Fibrosis
Trial Timeline
Oct 23, 2019 → Jul 11, 2022
NCT ID
NCT03924947About Pancrelipase + Pancrelipase
Pancrelipase + Pancrelipase is a approved stage product being developed by AbbVie for Cystic Fibrosis. The current trial status is completed. This product is registered under clinical trial identifier NCT03924947. Target conditions include Cystic Fibrosis.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03924947 | Approved | Completed |
Competing Products
20 competing products in Cystic Fibrosis